ENO1 Cancer Research Results
ENO1, α-Enolase: Click to Expand ⟱
| Source: |
| Type: |
Also known as 2-phospho-D-glycerate hydrolase
Is a glycolytic enzyme that catalyzes the conversion of 2-phosphoglyceric acid to phosphoenolpyruvic acid during glycolysis.
ENO1's glycolytic function deregulates cellular energetic, sustains tumor proliferation, and inhibits cancer cell apoptosis. Moreover, ENO1 evades growth suppressors and helps tumors to avoid immune destruction. Besides, ENO1 “moonlights” on the cell surface and acts as a plasminogen receptor, promoting cancer invasion and metastasis by inducing angiogenesis. Overexpression of ENO1 on a myriad of cancer types together with its localization on the tumor surface makes it a great prognostic and diagnostic cancer biomarker as well as an accessible oncotherapeutic target.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
BC, |
MDA-MB-453 |
|
|
|
Apoptosis↑, p‑ENO1↓, DNAdam↑, PI3K↑, p‑Akt↑, HER2/EBBR2↓,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Core Metabolism/Glycolysis ⓘ
p‑ENO1↓, 1,
Cell Death ⓘ
p‑Akt↑, 1, Apoptosis↑, 1,
Kinase & Signal Transduction ⓘ
HER2/EBBR2↓, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1,
Proliferation, Differentiation & Cell State ⓘ
PI3K↑, 1,
Clinical Biomarkers ⓘ
HER2/EBBR2↓, 1,
Total Targets: 7
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: ENO1, α-Enolase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:568 State#:1 Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page